Discontinued — last reported Q4 '24
Labcorp Holdings PP&E Sale Proceeds increased by 73.3% to $7.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1460.0%, from $500.00K to $7.80M. Over 4 years (FY 2021 to FY 2025), PP&E Sale Proceeds shows a downward trend with a -45.0% CAGR.
Significant proceeds may indicate a strategic shift, asset divestiture, or the replacement of obsolete equipment.
This represents cash inflows from the disposal of property, plant, and equipment. It reflects the company's strategy for...
Generally a minor line item unless the company is undergoing a major restructuring or facility consolidation.
proceeds_from_sale_of_ppe| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00K | $800.00K | $83.80M | $1.00M | $100.00K | $100.00K | $200.00K | $100.00K | $100.00K | $100.00K | $300.00K | $100.00K | $100.00K | $400.00K | $1.40M | $500.00K | $1.90M | $1.10M | $4.50M | $7.80M |
| QoQ Change | — | +700.0% | >999% | -98.8% | -90.0% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% | +200.0% | -66.7% | +0.0% | +300.0% | +250.0% | -64.3% | +280.0% | -42.1% | +309.1% | +73.3% |
| YoY Change | — | — | — | — | +0.0% | -87.5% | -99.8% | -90.0% | +0.0% | +0.0% | +50.0% | +0.0% | +0.0% | +300.0% | +366.7% | +400.0% | >999% | +175.0% | +221.4% | >999% |